TC 2696

Drug Profile

TC 2696

Alternative Names: TC-2696

Latest Information Update: 21 Apr 2008

Price : $50

At a glance

  • Originator Targacept
  • Class Analgesics; Small molecules
  • Mechanism of Action Nicotinic receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Pain

Most Recent Events

  • 07 Apr 2008 Discontinued - Phase-II for Pain in USA (unspecified route)
  • 04 Dec 2007 Phase II trial of TC 2696 in Pain fails to meet primary efficacy endpoints
  • 04 Dec 2007 Efficacy and adverse event data from a phase II trial in Pain released by Targacept
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top